Vifor Pharma Ltd.: 93rd Vifor Pharma Group Annual General Meeting
Election of Dr. Alexandre LeBeaut and Åsa Riisberg as Independent Directors
Dividend of CHF 2.00 approved
Regulatory News:
At today s 93
rd Annual General Meeting of Vifor Pharma Ltd., shareholders approved all proposed resolutions put forward by the Board of Directors. In view of the ongoing COVID-19 pandemic and in accordance with Ordinance 3 on measures to combat the coronavirus issued by the Swiss Federal Council, on the basis of Art. 8 of the new COVID-19 Act, shareholders were not permitted to attend the event in person. Shareholders exercised their rights exclusively through the independent proxy and 61.6% of the share capital was represented.
European Stocks Close Mixed After Cautious Session
BRUSSELS/FRANKFURT/PARIS (dpa-AFX) - European stocks ended mixed on Thursday as investors stayed largely cautious, tracking earnings announcements and digesting Bank of England s policy statement.
Although optimism about growth aided sentiment, buying interest was a bit subdued due to worries about spikes in coronavirus cases in Asian countries.
The Bank of England today kept its interest rate and quantitative easing unchanged. The nine-member Monetary Policy Committee, headed by Governor Andrew Bailey, unanimously voted to hold the interest rate at 0.10%.
The bank retained the stock of corporate bond purchases at GBP 20 billion and the government bond purchases at GBP 875 billion.
Share this article
Share this article
NEW YORK, May 6, 2021 /PRNewswire/ Around the world, 463 million adults had diabetes in 2019, and by 2045, this number is expected to rise to 700 million, as per the International Diabetes Federation (IDF). Similarly, the incidence of cancer, chronic obstructive pulmonary disease (COPD), asthma, and heart diseases, is rising. This factor will likely propel the global market for prefilled syringes from $1,914.1 million in 2020 to $3,646.7 million by 2030, at a 6.8% CAGR between 2021 and 2030, according to P&S Intelligence.
Such diseases require a regular administration of drugs, for which prefilled syringes are increasingly being used. In this regard, the rising usage of injectable pharmaceutical drugs is also driving the prefilled syringes market growth, since parenteral administration is one of the quickest ways of getting the drug to the target area inside the body. Prefilled syringes minimize drug wastage and the infection risk, thus pr
Search jobs 06-May-2021 Global Bioimpedance Devices Market Current and Future Trends, Leading Players, Industry Segments and Regional Forecast By 2028 | Says FMI Analyst
A recent market study published by FMI titled “
Bioimpedance Devices Market: Global Industry Analysis 2013–2017 and Opportunity Assessment 2018–2028” consists of a comprehensive assessment of the most important market dynamics. Following thorough research on the historic as well as current growth parameters of the bioimpedance devices market, growth prospects for the market have been obtained with maximum precision. The bioimpedance devices market report features unique and salient factors that are expected to significantly impact the development of the bioimpedance devices market during the forecast period.